El Hassani M - Search Results

1

Determination of 31 Antimicrobials in Human Serum Using Ultra-High Performance Liquid Chromatography With Diode Array Detection for Application in Therapeutic Drug Monitoring.

El-Haffaf I, El Hassani M, Marsot A. El-Haffaf I, et al. Among authors: el hassani m. Ther Drug Monit. 2024 Dec 17. doi: 10.1097/FTD.0000000000001284. Online ahead of print. Ther Drug Monit. 2024. PMID: 39688970

2

Development and Evaluation of a Height-Based Tobramycin Initial Dosing Nomogram for the Treatment of Adult Cystic Fibrosis Pulmonary Exacerbations.

El Hassani M, Thirion DJG, Koloskoff K, Matouk E, Simard C, Cloutier I, Pilote S, Marsot A. El Hassani M, et al. Ther Drug Monit. 2023 Apr 1;45(2):259-264. doi: 10.1097/FTD.0000000000001053. Ther Drug Monit. 2023. PMID: 36730982

3

Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?

El Hassani M, Liebchen U, Marsot A. El Hassani M, et al. Eur J Drug Metab Pharmacokinet. 2024 Jul;49(4):419-436. doi: 10.1007/s13318-024-00897-1. Epub 2024 May 5. Eur J Drug Metab Pharmacokinet. 2024. PMID: 38705941

4

Optimization of Vancomycin Initial Dosing Regimen in Neonates Using an Externally Evaluated Population Pharmacokinetic Model.

Blouin M, Métras MÉ, El Hassani M, Yaliniz A, Marsot A. Blouin M, et al. Among authors: el hassani m. Ther Drug Monit. 2024 Jun 6. doi: 10.1097/FTD.0000000000001226. Online ahead of print. Ther Drug Monit. 2024. PMID: 38857472

5

Authors' Reply to Lv et al.: "External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps".

El Hassani M, Marsot A. El Hassani M, et al. Clin Pharmacokinet. 2023 Aug;62(8):1187-1188. doi: 10.1007/s40262-023-01272-0. Epub 2023 Jun 23. Clin Pharmacokinet. 2023. PMID: 37351793 No abstract available.

6

Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses.

El Hassani M, Caissy JA, Marsot A. El Hassani M, et al. Clin Pharmacokinet. 2021 Apr;60(4):447-470. doi: 10.1007/s40262-020-00970-3. Epub 2021 Jan 15. Clin Pharmacokinet. 2021. PMID: 33447944

7

External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps.

El Hassani M, Marsot A. El Hassani M, et al. Clin Pharmacokinet. 2023 Apr;62(4):533-540. doi: 10.1007/s40262-023-01233-7. Epub 2023 Apr 1. Clin Pharmacokinet. 2023. PMID: 37004650

8

A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonates.

El Hassani M, Blouin M, Marsot A. El Hassani M, et al. Br J Clin Pharmacol. 2024 Dec 3. doi: 10.1111/bcp.16345. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 39628279

9

Consideration of height-based tobramycin dosing regimens for the treatment of adult cystic fibrosis pulmonary exacerbations.

El Hassani M, Simard C, Pilote S, Cloutier I, Soufsaf S, Marsot A. El Hassani M, et al. Br J Clin Pharmacol. 2022 May;88(5):2246-2255. doi: 10.1111/bcp.15154. Epub 2021 Dec 23. Br J Clin Pharmacol. 2022. PMID: 34820875 Free article.

10

External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first-order equations to Bayesian-guided therapeutic monitoring.

Blouin M, Métras MÉ, Gaudreault C, Dubé MH, Boulanger MC, Cloutier K, El Hassani M, Yaliniz A, Viel-Thériault I, Marsot A. Blouin M, et al. Among authors: el hassani m. Pharmacotherapy. 2024 Nov 15. doi: 10.1002/phar.4623. Online ahead of print. Pharmacotherapy. 2024. PMID: 39544156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters